In this webinar Professor Nicholas Zwar and Dr Sarah McGuiness present a case-based update on mosquito-borne diseases such as chikungunya, dengue, Japanese encephalitis, malaria, Yellow fever, and Zika, with a...
Across four short, sharp and topical MEDTalks, a vibrant, passionate panel of GPs and an epidemiologist will outline the latest considerations for GPs when deciding which COVID treatment to use, on whom, and...
Eosinophilic oesophagitis (EoE) is a differential diagnosis in adults presenting with symptoms of oesophageal dysfunction, such as difficulty or pain when swallowing.
Consider how your patient’s self-management behaviours, inhaled COPD medications and prescribed non-pharmacological treatments could be further optimised, to improve symptom control and reduce the risk of...
This 1.5-hour educational module explores how to identify affected patients with a family history of cancer and provides an overview of how Familial Cancer Centres can assist these patients through genetic...
In this clinical audit you will review the management of patients with type 2 diabetes and overweight or obesity.

Food cravings in people who are overweight or living with obesity

Food cravings are an intense desire to eat highly palatable and energy-dense foods and are among the main influencers of eating behaviour. In this module you will learn best practice steps to manage patients, then undertake a practical exercise to identify a patient who is overweight or living with obesity from your practice in order to reflect on latest evidence.

Updated management of HFrEF in general practice

[Expert video | Duration: 11:06] With new Australian consensus recommendations and available therapies for heart failure with reduced ejection fraction (HFrEF), GPs now have further options for optimising management of their HFrEF patients. Listen to Dr Chee Khoo discuss the updated recommendations and its implications for clinical practice, in both current and newly diagnosed patients.

The rising health threat of liver disease: What GPs can do to prevent premature mortality

Liver disease now affects up to 3 of every 10 Australian adults. Primary liver cancer is the most rapidly rising cause of cancer death. Health promotion, prevention, proactive case-finding, early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. Learn how to identify, manage and support your patients with liver disease.

Pages